
AdvanSure™ i3 Platform
AdvanSure™ i3 is an immunoassay platform based on magnetic particle chemiluminescence immunoassay (MP-CLIA).
It runs up to 9 samples at once* and delivers results within 15 minutes (1-step assay). It also supports LIS connection and Calibration/QC modes.
* May vary by reagent
AdvanSure™ i3 Reagent Portfolio
Fully automated testing, no reagent preparation, simple 3-step procedure, all-in-one cartridge
● Latent TB (AdvanSure™ i3 TB-IGRA)
A reagent that measures the interferon-gamma secreted in whole blood by T cells activated by Mycobacterium tuberculosis-specific antigens.
– South Korea's first MP-CLIA-based IFN-γ assay
– 15-minute TAT, wide measuring range of 0.16–200 IU/mL
– Testing right after centrifugation, with results the day after blood collection
● 5 Cardiac Marker Reagents (AdvanSure™ i3 Cardiac Markers)
– AdvanSure™ i3 cTnI: Reagent for cardiac troponin I testing
– AdvanSure™ i3 CK-MB: Reagent for creatine kinase (muscle/brain) testing
– AdvanSure™ i3 Myoglobin: Reagent for myocardial infarction testing
– AdvanSure™ i3 BNP: Reagent for heart failure testing
– AdvanSure™ i3 D-Dimer: Reagent for venous thromboembolism testing
● Sepsis Reagent (AdvanSure™ i3 PCT)
A reagent that quantifies procalcitonin (PCT) in human Na-heparin plasma and serum to aid in the diagnosis of sepsis
For product inquiries, please contact us through the website or reach out to your sales representative.